The National Prescribing Centre has published MeReC Extra 25 that provides an analysis and bottom line for two recent clinical trials and pointers to useful Hypertension and UTI guidance on the following areas.
Individual sections are available as follows:
- Statins after stroke: the SPARCL study
- MeReC Bulletin on hypertension: now available online
- Glitazones for preventing type 2 diabetes: the DREAM study
- SIGN guidance for UTI
Action: Clinicians involved in the treatment of stroke or diabetes will find the analysis of the recent SPARCL and DREAM studies useful. The MeReC Bulletin on Hypertension and the SIGN Guideline for Bacterial UTI will both be useful in primary care settings.
|« Counterfeit Test Strips||Generic prescribing for MR opiates »|